Fortitude Family Office »

Eliem Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $629 92 6.85

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
Braidwell
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors
Millennium Management
Vanguard Capital Management
Kynam Capital Management
Driehaus Capital Management
ADAR1 Capital Management
Susquehanna International
Nan Fung Trinity
Sphera Funds Management
BlackRock

View all funds holding Eliem Therapeutics